The imperative for increased investment for an HIV cure.

Simple item page
dc.contributor.authorvan Leeuwen R
dc.contributor.authorBarré-Sinoussi F
dc.contributor.authorMüller-Trutwin M
dc.contributor.authorSáez-Cirión A
dc.contributor.authorNijhuis M
dc.contributor.authorLewin SR
dc.contributor.authorNdung'u T
dc.contributor.authorRiako-Anam F
dc.contributor.authorWarren M
dc.contributor.authorSikazwe I
dc.contributor.authorPoniatowski B
dc.contributor.authorGrinsztejn B
dc.contributor.authorKityo C
dc.contributor.authorDavis M
dc.contributor.authorSøgaard OS
dc.contributor.authorAltfeld M
dc.contributor.authorMartinez-Picado J
dc.contributor.authorVandekerckhove L
dc.contributor.authorGramatica A
dc.contributor.authorSok D
dc.contributor.authorCollins S
dc.contributor.authorYazdanpanah Y
dc.date.accessioned2025-09-17T10:25:26Z
dc.date.issued2025-Jul-22
dc.identifier.doi10.1016/S2352-3018(25)00193-6
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/11794
dc.identifier.uri.pubmedhttps://pubmed.ncbi.nlm.nih.gov/40712628/
dc.relation.affiliationAidsfonds-Soa Aids Nederland, 1014 AX Amsterdam, Netherlands. Electronic address: rvanleeuwen@soaaids.nl.
dc.relation.affiliationSidaction, Paris, France; Institut Pasteur, Université Paris Cité, Paris, France.
dc.relation.affiliationInstitut Pasteur, Université Paris Cité, Paris, France.
dc.relation.affiliationSidaction, Paris, France; Institut Pasteur, Université Paris Cité, Paris, France.
dc.relation.affiliationUniversity Medical Centre Utrecht, Spiral Research Consortium, Utrecht, Netherlands; HIV Pathogenesis Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
dc.relation.affiliationDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection, Melbourne, VIC, Australia.
dc.relation.affiliationAfrica Health Research Institute, Durban, South Africa; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa; Ragon Institute of Massachusetts General, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA; Division of Infection and Immunity, University College London, London UK.
dc.relation.affiliationGlobal Network of People living with HIV, Johannesburg, South Africa.
dc.relation.affiliationAIDS Vaccine Advocacy Coalition, New York, NY, USA.
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationInternational Aids Society, Geneva, Switzerland.
dc.relation.affiliationInternational Aids Society, Geneva, Switzerland; FIOCRUZ HIV/AIDS Service, Rio de Janeiro, Brazil.
dc.relation.affiliationJoint Clinical Research Centre, Kampala, Uganda.
dc.relation.affiliationFunders Concerned About AIDS, Washington, DC, USA.
dc.relation.affiliationAarhus University Hospital, Aarhus, Denmark.
dc.relation.affiliationGerman Centre for Infectious Diseases Research, Leipzig, Germany; Leibniz-Institute of Virology, Leipzig, Germany.
dc.relation.affiliationIrsiCaixa, Barcelona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, Spain.
dc.relation.affiliationDepartment of General Internal Medicine in the Ghent University Hospital, Ghent, Belgium.
dc.relation.affiliationamfAR, New York, NY, USA.
dc.relation.affiliationGlobal Health Investment Corporation, New York, NY, USA.
dc.relation.affiliationEuropean AIDS Treatment Group, Brussels, Belgium; HIV i-Base, London, UK.
dc.relation.affiliationANRS Emerging Infectious Diseases, Paris, France.
dc.sourceThe lancet. HIV
dc.titleThe imperative for increased investment for an HIV cure.

Files

Collections

Published